B
BLCO
Bausch + Lomb Corporation
$16.04
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Bausch + Lomb Corporation in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.48
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $0.22
Oct 28
Posts
No posts about BLCO yet.
About Bausch + Lomb Corporation
Bausch + Lomb is a Canadian-based eye-health company. It sells contact lenses, lens-care solutions, eye drops, surgical equipment and prescription eye medicines to consumers, eye doctors and hospitals around the world. Parent company Bausch Health still controls it, even though Bausch + Lomb has traded as its own public company since 2022.